Getting your player ready...
WASHINGTON — The Food and Drug Administration on Friday approved the first drug to treat infantile spasms, a rare disorder that can cause hundreds of seizures per day in children less than a year old.
Sabril is an oral solution from Deerfield, Ill.-based Lundbeck Inc., approved for children between the ages of 1 month and 2 years. Infantile spasms usually occur while babies are eating or waking up, and often come in clusters of up to 100.
